Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.
- 1 December 1982
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 79 (23) , 7504-7508
- https://doi.org/10.1073/pnas.79.23.7504
Abstract
The purified MW 340,000 glycoprotein component of Epstein-Barr (EB) virus-induced membrane antigen complex incorporated into liposomes was shown to be a potent immunogen in mice. High-titer antisera were induced that are specific for membrane antigen components without absorption, bind the antigens induced by 3 different EB virus isolates and neutralize the ability of the virus to transform fetal cord blood lymphocytes in vitro. The development of this immunogenic form of purified antigen provides an important step towards a potential subunit vaccine against EB virus infection.Keywords
This publication has 35 references indexed in Scilit:
- Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodiesInternational Journal of Cancer, 1981
- Antigenic Differences between the Membrane Antigen Polypeptides Determined by Different EB Virus IsolatesJournal of General Virology, 1981
- Biochemical characterization of Epstein-Barr Virus membrane antigen associated glycoproteinsBiochemical and Biophysical Research Communications, 1981
- Observations on the EB virus envelope and virus‐determined membrane antigen (MA) polypeptidesInternational Journal of Cancer, 1980
- Epstein‐Barr virus‐induced membrane antigens: Immunochemical characterization of triton X‐100 solubilized viral membrane antigens from EBV‐superinfected raji cellsInternational Journal of Cancer, 1979
- Hepatitis B surface antigen‐containing liposomes enhance humoral and cell‐mediated immunity to the antigenFEBS Letters, 1979
- Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti‐MA)International Journal of Cancer, 1974
- Assay of the Infectivity of Epstein-Barr Virus by Transformation of Human Leucocytes in vitroJournal of General Virology, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- ESTABLISHMENT OF CELL LINES FROM AUSTRALIAN LEUKAEMIC PATIENTS: PRESENCE OF A HERPES‐LIKE VIRUSImmunology & Cell Biology, 1968